Ipsen’s Acquisition of Epizyme

Orrick Herrington & Sutcliffe advised Ipsen on the deal. Global biopharmaceutical company Ipsen (Euronext: IPN; ADR: IPSEY) announced its definitive agreement to acquire Epizyme (Nasdaq: EPZM), a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Invision’s Acquisition of eduPRO

SKYE PARTNERS, Pusch Wahlig, BCA-Law, DMZ Legal, Herrmann legal, Herbst Kinsky, HFK Rechtsanwälte and lindenpartners advised Invision on the deal. Orrick Herrington & Sutcliffe advised Luxempart...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

IONITY’s €700 Million Capital Investment

Linklaters advised BlackRock’s Global Renewable Power platform on the deal while Orrick advised IONITY. BlackRock’s Global Renewable Power platform on its an investment in the charging...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here